Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2006-4-19
pubmed:abstractText
Aberrant methylation of CpG islands located at or near gene promoters is associated with inactivation of gene expression during tumour development. It is increasingly recognised that such epimutations may occur at a much higher frequency than gene mutation and therefore have a greater impact on selection of subpopulations of cells during tumour progression or acquisition of resistance to anticancer drugs. Although laboratory-based models of acquired resistance to anticancer agents tend to focus on specific genes or biochemical pathways, such 'one gene:one outcome' models may be an oversimplification of acquired resistance to treatment of cancer patients. Instead, clinical drug resistance may be due to changes in expression of a large number of genes that have a cumulative impact on chemosensitivity. Aberrant CpG island methylation of multiple genes occurring in a nonrandom manner during tumour development and during the acquisition of drug resistance provides a mechanism whereby expression of multiple genes could be affected simultaneously resulting in polygenic clinical drug resistance. If simultaneous epigenetic regulation of multiple genes is indeed a major driving force behind acquired resistance of patients' tumour to anticancer agents, this has important implications for biomarker studies of clinical outcome following chemotherapy and for clinical approaches designed to circumvent or modulate drug resistance.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/16495912-10327053, http://linkedlifedata.com/resource/pubmed/commentcorrection/16495912-10655057, http://linkedlifedata.com/resource/pubmed/commentcorrection/16495912-10734209, http://linkedlifedata.com/resource/pubmed/commentcorrection/16495912-10802938, http://linkedlifedata.com/resource/pubmed/commentcorrection/16495912-11070098, http://linkedlifedata.com/resource/pubmed/commentcorrection/16495912-11085525, http://linkedlifedata.com/resource/pubmed/commentcorrection/16495912-11196646, http://linkedlifedata.com/resource/pubmed/commentcorrection/16495912-11309270, http://linkedlifedata.com/resource/pubmed/commentcorrection/16495912-11433041, http://linkedlifedata.com/resource/pubmed/commentcorrection/16495912-11593392, http://linkedlifedata.com/resource/pubmed/commentcorrection/16495912-11773279, http://linkedlifedata.com/resource/pubmed/commentcorrection/16495912-12095266, http://linkedlifedata.com/resource/pubmed/commentcorrection/16495912-12114427, http://linkedlifedata.com/resource/pubmed/commentcorrection/16495912-12142371, http://linkedlifedata.com/resource/pubmed/commentcorrection/16495912-12154064, http://linkedlifedata.com/resource/pubmed/commentcorrection/16495912-12163700, http://linkedlifedata.com/resource/pubmed/commentcorrection/16495912-12351408, http://linkedlifedata.com/resource/pubmed/commentcorrection/16495912-12394273, http://linkedlifedata.com/resource/pubmed/commentcorrection/16495912-12425956, http://linkedlifedata.com/resource/pubmed/commentcorrection/16495912-12529460, http://linkedlifedata.com/resource/pubmed/commentcorrection/16495912-12610533, http://linkedlifedata.com/resource/pubmed/commentcorrection/16495912-12648673, http://linkedlifedata.com/resource/pubmed/commentcorrection/16495912-12692539, http://linkedlifedata.com/resource/pubmed/commentcorrection/16495912-12724229, http://linkedlifedata.com/resource/pubmed/commentcorrection/16495912-12730288, http://linkedlifedata.com/resource/pubmed/commentcorrection/16495912-12835670, http://linkedlifedata.com/resource/pubmed/commentcorrection/16495912-12957287, http://linkedlifedata.com/resource/pubmed/commentcorrection/16495912-14604977, http://linkedlifedata.com/resource/pubmed/commentcorrection/16495912-15057289, http://linkedlifedata.com/resource/pubmed/commentcorrection/16495912-15077155, http://linkedlifedata.com/resource/pubmed/commentcorrection/16495912-15094809, http://linkedlifedata.com/resource/pubmed/commentcorrection/16495912-15150090, http://linkedlifedata.com/resource/pubmed/commentcorrection/16495912-15164071, http://linkedlifedata.com/resource/pubmed/commentcorrection/16495912-15240532, http://linkedlifedata.com/resource/pubmed/commentcorrection/16495912-15270655, http://linkedlifedata.com/resource/pubmed/commentcorrection/16495912-15297393, http://linkedlifedata.com/resource/pubmed/commentcorrection/16495912-15315754, http://linkedlifedata.com/resource/pubmed/commentcorrection/16495912-15536519, http://linkedlifedata.com/resource/pubmed/commentcorrection/16495912-15894365, http://linkedlifedata.com/resource/pubmed/commentcorrection/16495912-15967110, http://linkedlifedata.com/resource/pubmed/commentcorrection/16495912-16204069, http://linkedlifedata.com/resource/pubmed/commentcorrection/16495912-16234563, http://linkedlifedata.com/resource/pubmed/commentcorrection/16495912-7923117, http://linkedlifedata.com/resource/pubmed/commentcorrection/16495912-8094031, http://linkedlifedata.com/resource/pubmed/commentcorrection/16495912-8402885, http://linkedlifedata.com/resource/pubmed/commentcorrection/16495912-90553, http://linkedlifedata.com/resource/pubmed/commentcorrection/16495912-9171110, http://linkedlifedata.com/resource/pubmed/commentcorrection/16495912-9916800, http://linkedlifedata.com/resource/pubmed/commentcorrection/16495912-9949205
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0007-0920
pubmed:author
pubmed:issnType
Print
pubmed:day
24
pubmed:volume
94
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1087-92
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
Epigenetics as a mechanism driving polygenic clinical drug resistance.
pubmed:affiliation
Centre for Oncology and Applied Pharmacology, Glasgow University, CRUK Beatson Laboratories, Garscube Estate, Glasgow G61 1BD, UK.
pubmed:publicationType
Journal Article, Review